X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13500) 13500
Newsletter (2456) 2456
Book Review (1628) 1628
Publication (1024) 1024
Conference Proceeding (87) 87
Book Chapter (45) 45
Newspaper Article (38) 38
Magazine Article (35) 35
Dissertation (30) 30
Report (6) 6
Web Resource (3) 3
Trade Publication Article (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lamivudine (10268) 10268
humans (9643) 9643
index medicus (9545) 9545
male (5307) 5307
female (5086) 5086
hepatitis b (4829) 4829
adult (4753) 4753
lamivudine - therapeutic use (4203) 4203
middle aged (3633) 3633
antiviral agents - therapeutic use (3258) 3258
hepatitis b, chronic - drug therapy (3003) 3003
hepatitis b virus (2890) 2890
hiv infections - drug therapy (2880) 2880
infectious diseases (2841) 2841
gastroenterology & hepatology (2807) 2807
treatment outcome (2375) 2375
drug therapy, combination (2175) 2175
therapy (2155) 2155
virology (2104) 2104
hiv (2030) 2030
hepatitis b virus - genetics (2022) 2022
infection (1897) 1897
care and treatment (1869) 1869
anti-hiv agents - therapeutic use (1865) 1865
research (1748) 1748
drug therapy (1722) 1722
viral load (1714) 1714
pharmacology & pharmacy (1706) 1706
reverse transcriptase inhibitors - therapeutic use (1655) 1655
immunology (1586) 1586
hepatitis b virus - drug effects (1579) 1579
tenofovir (1577) 1577
aids/hiv (1567) 1567
adenine - analogs & derivatives (1527) 1527
antiviral agents (1502) 1502
lamivudine - administration & dosage (1494) 1494
mutation (1445) 1445
zidovudine (1381) 1381
health aspects (1378) 1378
aged (1359) 1359
dna, viral - blood (1267) 1267
entecavir (1252) 1252
hepatitis b, chronic - virology (1232) 1232
hepatitis (1186) 1186
adefovir dipivoxil (1185) 1185
hepatitis b - drug therapy (1123) 1123
antiretroviral therapy (1114) 1114
adenine - therapeutic use (1105) 1105
interferon (1094) 1094
drugs (1091) 1091
adolescent (1080) 1080
medical research (1078) 1078
chronic hepatitis b (1072) 1072
hiv infections - virology (1020) 1020
lamivudine - pharmacology (1014) 1014
drug resistance, viral (1003) 1003
analysis (998) 998
zidovudine - therapeutic use (994) 994
resistance (987) 987
medicine, experimental (985) 985
organophosphonates - therapeutic use (979) 979
drug resistance (974) 974
microbiology (968) 968
retrospective studies (948) 948
hepatitis b e antigens - blood (891) 891
risk factors (888) 888
dna (886) 886
hiv-1 - drug effects (883) 883
genotype (871) 871
cd4 lymphocyte count (860) 860
time factors (855) 855
transplantation (855) 855
guanine - analogs & derivatives (842) 842
antiviral agents - administration & dosage (834) 834
aids (821) 821
anti-hiv agents - administration & dosage (819) 819
efficacy (810) 810
human immunodeficiency virus--hiv (809) 809
virus diseases (803) 803
young adult (803) 803
antiviral agents - pharmacology (794) 794
hiv infection (792) 792
abridged index medicus (781) 781
adefovir (762) 762
lamivudine - adverse effects (762) 762
antiretroviral drugs (759) 759
hepatocellular-carcinoma (755) 755
liver (755) 755
combination (727) 727
prevention (718) 718
virus-infection (714) 714
mutations (711) 711
liver transplantation (709) 709
replication (709) 709
lamivudine therapy (694) 694
medicine, general & internal (688) 688
follow-up studies (675) 675
hbv (669) 669
recurrence (663) 663
anti-hiv agents - adverse effects (654) 654
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14751) 14751
Korean (327) 327
Chinese (293) 293
French (174) 174
Spanish (159) 159
German (132) 132
Japanese (92) 92
Portuguese (45) 45
Polish (40) 40
Hungarian (27) 27
Turkish (27) 27
Russian (22) 22
Czech (14) 14
Dutch (13) 13
Italian (11) 11
Danish (6) 6
Romanian (3) 3
Serbian (3) 3
Croatian (2) 2
Lithuanian (2) 2
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Persian (1) 1
Slovak (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2018, Volume 48, Issue 4, p. S152
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.medmal.2018.04.380 La... 
Lamivudine
Journal Article
Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2016, Volume 46, Issue 4, p. 124
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 06/2015, Volume 22, Issue S2, pp. 35 - 35
Journal Article
Bulletin de la Societe de pathologie exotique, ISSN 0037-9085, 02/2013, Volume 106, Issue 1, p. 22
L'objectif de cette etude est de mesurer l'efficacite et d'evaluer la tolerance de l'association tenofovir-lamivudine-efavirenz (TDF-3TC-EFV) par une etude... 
Lamivudine
Journal Article
WHO Drug Information, ISSN 1010-9609, 01/2015, Volume 29, Issue 1, p. 26
Journal Article
Gastroenterology, ISSN 0016-5085, 2009, Volume 136, Issue 2, pp. 486 - 495
Background & Aims The GLOBE trial has compared the efficacy and safety of telbivudine versus lamivudine treatment over 2 years in patients with chronic... 
Gastroenterology and Hepatology | VIRAL LOAD | E-ANTIGEN | ENTECAVIR | THERAPY | VIRUS | POSITIVE CHRONIC HEPATITIS | ADEFOVIR DIPIVOXIL | RISK | NATURAL-HISTORY | YMDD VARIANTS | GASTROENTEROLOGY & HEPATOLOGY | Prospective Studies | Humans | Middle Aged | Male | Alanine Transaminase - blood | Hepatitis B Surface Antigens - blood | Lamivudine - adverse effects | Young Adult | Lamivudine - therapeutic use | Nucleosides - pharmacology | Adult | Female | Hepatitis B, Chronic - blood | Pyrimidinones - pharmacology | Hepatitis B virus - immunology | Nucleosides - therapeutic use | Virus Replication - drug effects | Antiviral Agents - pharmacology | DNA, Viral - drug effects | Double-Blind Method | Global Health | Antiviral Agents - therapeutic use | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Treatment Outcome | Nucleosides - adverse effects | Regression Analysis | Hepatitis B, Chronic - drug therapy | Thymidine - analogs & derivatives | Antiviral Agents - adverse effects | Adolescent | Hepatitis B virus - genetics | Aged | Lamivudine - pharmacology | Hepatitis B e Antigens - blood | Longitudinal Studies | Polymerase chain reaction | Care and treatment | Creatine kinase | Analysis | Gastrointestinal diseases | Clinical trials | Lamivudine | Creatine | Hepatitis B | Index Medicus | Abridged Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 12/2014, Volume 312, Issue 23, pp. 2521 - 2530
IMPORTANCE: Hepatitis B virus (HBV) reactivation is a serious complication for patients with lymphoma treated with rituximab-containing chemotherapies, despite... 
PROPHYLACTIC LAMIVUDINE | CYTOTOXIC CHEMOTHERAPY | MEDICINE, GENERAL & INTERNAL | SEROPOSITIVE CANCER-PATIENTS | HBV REACTIVATION | PREEMPTIVE LAMIVUDINE | PLUS RITUXIMAB | NON-HODGKINS-LYMPHOMA | HIGH PREVALENCE | ELDERLY-PATIENTS | DES-LYMPHOMES | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Guanine - analogs & derivatives | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Hepatitis B Surface Antigens - blood | Lamivudine - adverse effects | Young Adult | Lamivudine - therapeutic use | Vincristine - administration & dosage | Adult | Female | Guanine - adverse effects | Hepatitis B virus - immunology | Guanine - therapeutic use | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Antiviral Agents - therapeutic use | Rituximab | Lymphoma, Large B-Cell, Diffuse - virology | Hepatitis B - etiology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antiviral Agents - adverse effects | Aged | Hepatitis B - prevention & control | Antibodies, Monoclonal, Murine-Derived - adverse effects | Clinical trials | Hepatitis | Chemotherapy | Lymphomas | Antiviral drugs | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2008, Volume 198, Issue 8, pp. 1113 - 1122
Background. Vicriviroc (VCV) is a CCR5 antagonist with nanomolar activity against human immunodeficiency virus (HIV) replication in vitro and in vivo. We... 
HIV/AIDS | Tropisms | RNA | HIV | Placebos | Viruses | AIDS | Infections | Dosage | HIV 1 | Virology | INFECTIOUS DISEASES | MYOCARDIAL-INFARCTION | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | PROGNOSTIC VALUE | CCR5 ANTAGONIST | INDIVIDUALS | ANTIRETROVIRAL-DRUG-RESISTANCE | SYNCYTIUM-INDUCING PHENOTYPE | EPIDEMIOLOGY | DISEASE PROGRESSION | Piperazines - administration & dosage | Lamivudine - administration & dosage | Humans | Male | RNA, Viral - blood | Reverse Transcriptase Inhibitors - administration & dosage | Viral Load | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | HIV-1 - physiology | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | CCR5 Receptor Antagonists | Benzoxazines - administration & dosage | Double-Blind Method | Zidovudine - adverse effects | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | HIV Infections - virology | Benzoxazines - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Piperazines - therapeutic use | Piperazines - adverse effects | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | HIV Infections - drug therapy | Zidovudine - therapeutic use | Lamivudine | Dosage and administration | HIV (Viruses) | Drug therapy | Zidovudine | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 19, pp. 1807 - 1818
Journal Article
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2017, Volume 23, Issue 41, pp. 7459 - 7469
AIM To demonstrate the non-inferiority(15% non-inferiority limit) of monotherapy with tenofovir disoproxil fumarate(TDF) vs the combination of lamivudine(LAM)... 
Adherence | Tenofovir | Lamivudine+Adefovir | Costs | Efficacy | Safety | Hepatitis B | VIRUS-INFECTION | MONOTHERAPY | Lamivudine plus Adefovir | EMTRICITABINE | NATURAL-HISTORY | DIPIVOXIL | COMBINATION | THERAPY | DISOPROXIL FUMARATE | RESISTANCE | GASTROENTEROLOGY & HEPATOLOGY | IN-VITRO ACTIVITY | Hepatitis B e Antigens - immunology | Prospective Studies | Hepatitis B, Chronic - immunology | Humans | Middle Aged | Tenofovir - pharmacology | DNA, Viral - isolation & purification | Drug Resistance, Viral | Male | Alanine Transaminase - blood | Tenofovir - economics | Adenine - economics | Drug Therapy, Combination - adverse effects | Adenine - therapeutic use | Treatment Failure | Lamivudine - therapeutic use | Adult | Female | Hepatitis B, Chronic - blood | Hospital Costs - statistics & numerical data | Organophosphonates - economics | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Tenofovir - therapeutic use | Antiviral Agents - therapeutic use | Hepatitis B Surface Antigens - immunology | Adenine - pharmacology | Drug Therapy, Combination - economics | Hepatitis B virus - physiology | Hepatitis B virus - drug effects | Drug Therapy, Combination - methods | Organophosphonates - pharmacology | Hepatitis B, Chronic - drug therapy | Aged | Lamivudine - economics | Lamivudine - pharmacology | Antiviral Agents - economics | Viral Load - drug effects | Index Medicus | Randomized Controlled Trial
Journal Article
Journal of Hazardous Materials, ISSN 0304-3894, 12/2011, Volume 197, p. 229
a* Photocatalytic degradation kinetics of antivirus drug lamivudine. a* The degradation kinetics was optimized by the single-variable-at-a-time. a* The... 
Sulfonamides | Lamivudine
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2008, Volume 48, Issue 5, pp. 728 - 735
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2007, Volume 357, Issue 25, pp. 2576 - 2588
Journal Article